High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Br J Haematol. 2019 Jan;184(2):192-201. doi: 10.1111/bjh.15703. Epub 2018 Dec 2.

Abstract

Plasma cells are important prognostic actors in different malignancies. The tumour microenvironmental composition in classic Hodgkin lymphoma (cHL) is a major prognostic key element; however, clinicopathological studies regarding plasma cells in cHL are lacking. The aim of this study was to investigate CD138+ (also termed SDC1+) plasma cell and IgG4 producing (IgG4+) plasma cells infiltration in the microenvironment of cHL. Immunohistochemistry with anti-CD138 and IgG4 antibodies was performed on diagnostic tumour biopsies from 124 patients with cHL, on tissue micro array (TMA). In 120 cases, CD138+ plasma cell-infiltration was associated with the presence of B-symptoms (P = 0·028) and advanced stage, IIB-IVB (P = 0·009). In multivariate analysis, CD138+ plasma cells correlated with eosinophil infiltration (P = 0·013). The subgroup of IgG4+ plasma cells was analysed in 122 cases and only correlated to CD138+ plasma cells (P = 0·004). Patients with high proportion of tumour infiltrating CD138+ plasma cells (defined as ≥10%), had a more inferior event-free survival (P = 0·007) and overall survival (P = 0·004) than patients with a low proportion of infiltrating CD138+ plasma cells (<10%), although significance was not maintained in multivariate analysis. In summary, a high proportion of tumour-associated plasma cells in cHL reflect an important component in the microenvironment of cHL.

Keywords: CD138 plasma cells; Hodgkin's lymphoma; IgG4-producing plasma cells; Syndecan-1; tumour microenvironment.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Hodgkin Disease* / metabolism
  • Hodgkin Disease* / mortality
  • Hodgkin Disease* / pathology
  • Humans
  • Immunoglobulin G / metabolism*
  • Kaplan-Meier Estimate
  • Lymphoma, B-Cell* / metabolism
  • Lymphoma, B-Cell* / mortality
  • Lymphoma, B-Cell* / pathology
  • Male
  • Middle Aged
  • Neoplasm Proteins / metabolism*
  • Plasma Cells* / metabolism
  • Plasma Cells* / pathology
  • Survival Rate
  • Syndecan-1 / metabolism*
  • Tumor Microenvironment*

Substances

  • Immunoglobulin G
  • Neoplasm Proteins
  • SDC1 protein, human
  • Syndecan-1